scorecard

You Searched For "johnson johnson" and got 20 results


Sort By:


Business Insider Latest Story Image
1 min read

Johnson & Johnson plans to buy back shares up to $10 bln

The company said on Tuesday it had about 2.77 billion shares of common stock outstanding as of Sept…

Business Insider Latest Story Image
2 mins read

The US recommended suspending the Johnson & Johnson vaccine just as Europe was about to start using it

US health agencies temporarily suspended the use of the vaccine just as 55 million doses started be…

Marianne Guenot   


Business Insider Latest Story Image
1 min read

Single shot Covid-19 vaccine shows 66% efficacy overall: Johnson & Johnson

Johnson & Johnson on Friday said its single-shot vaccine has been found to be 66 per cent effective…

Business Insider Latest Story Image
1 min read

The CEO of the biotech firm that ruined Johnson & Johnson vaccine doses told CNBC 'it was one batch'

Kramer said there wasn't cross-contamination of ingredients, but that doses were pulled because of …

Azmi Haroun   


Business Insider Latest Story Image
2 mins read

Johnson & Johnson falls despite earnings beat after pausing COVID-19 vaccine trial over 'unexplained illness'

Johnson & Johnson's COVID-19 vaccine is being developed by its Janssen pharmaceutical unit and is i…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Johnson & Johnson beats earnings expectations

In the earnings release, CEO Alex Gorsky said: "Our solid sales and earnings results in the quarter…

Akin Oyedele   


Business Insider Latest Story Image
1 min read

Johnson & Johnson is delaying the rollout of its COVID-19 vaccine in Europe after US officials recommended pausing its use

The US CDC advised health officials to stop giving the shots out of an "abundance of caution" becau…

Paul Squire   


Business Insider Latest Story Image
3 mins read

Millions of Johnson & Johnson COVID-19 vaccines are set to expire this month, and states are scrambling to use up their stockpiles or send them abroad

US states are racing to use up stocks of the Johnson & Johnson vaccine, or send them elsewhere. Pub…

Grace Dean   


Business Insider Latest Story Image
2 mins read

Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover

The deal values Momenta at $52.50 per share, a 70.4% premium to its Wednesday close. The deal is ex…

Ben Winck   


Business Insider Latest Story Image
1 min read

Trump and Biden officials knew about quality-control problems at the Baltimore facility that ruined 15 million COVID-19 vaccine doses, report says

The Emergent BioSolutions plant unknowingly cross-contaminated some 15 million doses of the J&J vac…

Sinéad Baker   


Business Insider Latest Story Image
2 mins read

Kelly McLaughlin   


Business Insider Latest Story Image
2 mins read

The factory that had to toss J&J coronavirus vaccines has made 150 million doses. Regulators haven't let any reach the public.

The factory hasn't been certified by regulators to distribute the doses to the public, the New York…

Kelly McLaughlin   


Business Insider Latest Story Image
1 min read

Manufacturer that ruined 15 million Johnson & Johnson vaccine doses once got a $163 million federal contract to improve its facility: NYT

The federal government first invested in the Emergent BioSolutions more than eight years ago, the N…

Kelly McLaughlin   


Business Insider Latest Story Image
1 min read

States are only getting 700,000 Johnson & Johnson vaccine doses next week, down from almost 5 million this week

The distribution of the Johnson & Johnson COVID-19 vaccine has been varied for weeks, according to …

Kelly McLaughlin   


Business Insider Latest Story Image
1 min read

Johnson & Johnson has begun testing its vaccine in adolescents between 12 and 17 years old

Johnson & Johnson announced in a statement that it's expanding its clinical trials to include adole…

Kelly McLaughlin   


Business Insider Latest Story Image
1 min read

US drug regulator says Johnson & Johnson's Covid-19 vaccine safe and effective

The US is on the cusp of getting a third vaccine against Covid-19. The US Food and Drug Administrat…

Business Insider Latest Story Image
1 min read

The EMA found a possible link between the Johnson & Johnson COVID-19 vaccine and 'unusual blood clots' and wants a warning attached

The European Medicines Agency said blood clots should be listed as "very rare side effects" of the …

Kelly McLaughlin   


Business Insider Latest Story Image
1 min read

Fauci defended pausing the Johnson & Johnson COVID-19 vaccine rollout but said those who already got the shot shouldn't worry

US authorities urged a pause in the vaccine's rollout Tuesday, citing an "abundance of caution" ove…

Sinéad Baker   


Business Insider Latest Story Image
3 mins read

Company involved in 15 million discarded doses of the J&J vaccine has history of quality control violations

The company is at the center of the mix-up that led to roughly 15 million discarded doses of the Jo…

Lauren Frias   


Business Insider Latest Story Image
1 min read

White House says Johnson & Johnson pause 'will not have a significant impact on our vaccination plan'

White House COVID-19 Response Coordinator Jeff Zients released a statement on the Johnson & Johnson…

Kelly McLaughlin